G6PD Deficiency Reference Guide
G6PD Deficiency Reference Guide What is G6PD Deficiency? Medications to Avoid Analgesics / Antipyretics acetanilid, acetophenetidin (phenacetin), amidopyrine (aminopyrine) *,
Download G6PD Deficiency Reference Guide
Information
Domain:
Source:
Link to this page:
Related documents
Dispersible Aspirin 75mg Tablets BP PL 17907 0155-6
www.mhra.gov.ukMHRA PAR – Dispersible Aspirin 75mg Tablets BP (PL 17907/0155-6) - 2 - DISPERSIBLE ASPIRIN 75MG TABLETS BP PL 17907/0155-6 LAY SUMMARY The MHRA granted Bristol Laboratories Limited Marketing Authorisations (licences) for
Patient Information Leaflet QUININE BISULPHATE 300MG …
www.mhra.gov.ukPatient Information Leaflet QUININE BISULPHATE 300MG TABLETS Read all of this leaflet carefully before you start taking this medicine because it contains
Generic Name Chloroquine Proguanil Mefloquine Doxycycline ...
www.janechiodini.co.ukGeneric Name Chloroquine Proguanil Mefloquine Doxycycline Atovaquone / Proguanil Dosage and administration 310mg base (2 tablets) weekly 200mg (2 tablets)
CODING AT A GLANCE - krystexxahcp.com
www.krystexxahcp.comINDICATION AND IMPORTANT SAFETY INFORMATION Reference: 1. KRYSTEXXA [prescribing information]. Horizon Pharma Rheumatology LLC. INDICATIONS AND USAGE
INFUSION REACTION PROPHYLAXIS - krystexxahcp.com
www.krystexxahcp.comINDICATION AND IMPORTANT SAFETY INFORMATION INDICATIONS AND USAGE KRYSTEXXA® (pegloticase) is indicated for the treatment of chronic gout in adult patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically